# Junta clínica — PT-pseudo_b28f2ad6069e (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_b28f2ad6069e",
  "pid": "PT-pseudo_b28f2ad6069e",
  "task": 1,
  "psa": 19.0,
  "age": 64,
  "months": 2,
  "pirads": "4",
  "psad": 0.217,
  "psav": 5.89,
  "psap": 25.8,
  "vol": 87.5,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.7858892,
  "medhx": "Hypertension, Chronic kidney disease, Benign prostatic hyperplasia",
  "meds": "amlodipine, valsartan, metoprolol",
  "notes": "PSA 19 ng/mL. PI-RADS 4. PSAD 0.22. Prostate volume 88 mL. csPCa 0.79.",
  "pmhx": [
    "Hypertension",
    "Chronic kidney disease",
    "Benign prostatic hyperplasia"
  ],
  "allergies": [],
  "vitals": {
    "weight": "72 kg",
    "height": "166 cm",
    "bmi": "26.1",
    "bp": "134/72 mmHg",
    "hr": "87 bpm",
    "smoking": "Ex-smoker (27 pack-yr, quit 2018)",
    "last_dental": "6 mo ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "15 Feb 2025",
  "enc_ref": "Dr. C. Peters (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical assessment requested after earlier biopsy confirmation and latest multiparametric MRI results."
    },
    {
      "s": "History",
      "t": "At 64 years of age, this retired warehouse worker initially came to medical attention due to an incidental PSA elevation noted in late 2022. He is married and currently resides on his own. His medical background encompasses hypertension and chronic kidney disease, managed through amlodipine, valsartan, and metoprolol. Benign prostatic hyperplasia is also part of his clinical picture. He reports minimal lower urinary tract symptoms, scoring a 1 on the IPSS questionnaire. Alcohol consumption remains steady at roughly nine units weekly. A former smoker, he accumulated 27 pack-years before ceasing in 2018. Physical activity is limited to chair-based exercises, though his adult son provides regular support. Aside from urological concerns, he deals with mild bilateral knee osteoarthritis and recently visited audiology for a standard hearing check. He has expressed significant apprehension about invasive interventions, asking for extended time to review potential directions."
    },
    {
      "s": "Physical examination",
      "t": "DRE — texture: smooth and rubbery; mobility: symmetrically enlarged; asymmetry: absent, no palpable nodules detected. General examination remains within normal limits. Blood pressure reads 134/72 mmHg, and heart rate is regular at 87 bpm. Palpation of the abdomen reveals a soft, non-tender surface without evidence of masses or organomegaly."
    }
  ],
  "occupation": "retired warehouse worker",
  "marital": "Married",
  "living": "Lives alone",
  "next_of_kin": "Adult son (primary contact)",
  "recent_other": [
    "Audiology — hearing test"
  ],
  "alcohol": "9 units / week",
  "exercise": "Limited mobility — chair-based exercises only",
  "ipss": "IPSS score: 1/35 (mild LUTS)",
  "admin": "Patient anxious about procedures — allocate extra consult time.",
  "mri_hospital": "OLVG (Amsterdam)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_b28f2ad6069e
Task: 1

Encounter: Urology - outpatient on 15 Feb 2025.
Referrer: Dr. C. Peters (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 64-year-old male
  - PSA: 19.0 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.217 ng/mL²
  - PSA velocity: 5.89 ng/mL/yr
  - Prior PSA: 25.8 ng/mL
  - Prostate volume: 87.5 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.7858892 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Hypertension, Chronic kidney disease, Benign prostatic hyperplasia
  - Problem list / PMHx: Hypertension, Chronic kidney disease, Benign prostatic hyperplasia
  - Current medication: amlodipine, valsartan, metoprolol
  - Allergies: NKA
  - Additional notes: PSA 19 ng/mL. PI-RADS 4. PSAD 0.22. Prostate volume 88 mL. csPCa 0.79.

Vitals: weight 72 kg, height 166 cm, BMI 26.1, BP 134/72 mmHg, HR 87 bpm. Smoking: Ex-smoker (27 pack-yr, quit 2018).

Chief complaint: Clinical assessment requested after earlier biopsy confirmation and latest multiparametric MRI results.

History: At 64 years of age, this retired warehouse worker initially came to medical attention due to an incidental PSA elevation noted in late 2022. He is married and currently resides on his own. His medical background encompasses hypertension and chronic kidney disease, managed through amlodipine, valsartan, and metoprolol. Benign prostatic hyperplasia is also part of his clinical picture. He reports minimal lower urinary tract symptoms, scoring a 1 on the IPSS questionnaire. Alcohol consumption remains steady at roughly nine units weekly. A former smoker, he accumulated 27 pack-years before ceasing in 2018. Physical activity is limited to chair-based exercises, though his adult son provides regular support. Aside from urological concerns, he deals with mild bilateral knee osteoarthritis and recently visited audiology for a standard hearing check. He has expressed significant apprehension about invasive interventions, asking for extended time to review potential directions.

Physical examination: DRE — texture: smooth and rubbery; mobility: symmetrically enlarged; asymmetry: absent, no palpable nodules detected. General examination remains within normal limits. Blood pressure reads 134/72 mmHg, and heart rate is regular at 87 bpm. Palpation of the abdomen reveals a soft, non-tender surface without evidence of masses or organomegaly.

Patient info: retired warehouse worker; Married; Lives alone.
Next of kin: Adult son (primary contact).

Lifestyle: alcohol 9 units / week; exercise Limited mobility — chair-based exercises only; IPSS score: 1/35 (mild LUTS).

Recent other appointments: Audiology — hearing test.
Admin: Patient anxious about procedures — allocate extra consult time.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.56
  uncertainty  +/- 0.08 epistemic (95% band 0.40-0.72); among patients I cannot tell apart the outcome was 0.99 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 3 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 64 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 19 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 87.5 mL (1% of my signal; from log_vol, vol) · PSA density = 0.217 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.79 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 64 · DRE = Normal · PSA = 19 ng/mL · prostate volume = 87.5 mL · PSA density = 0.217 · PI-RADS = 4 · comorbidity = 3 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 49 men I have seen in this same situation (Positive prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 1.49: PI-RADS 4, PSA 6.5, PSAD 0.11, age 64, DRE Normal -> DEFER (uncertain). He wrote: "Need initial ISUP grade and MRI in men on active surveillance."
  2. distance 1.54: PI-RADS 4, PSA 6.8, PSAD 0.2, age 62, DRE Normal -> DEFER (borderline). He wrote: "All depends if the lesion has grown in size since 2024. If stable no biopsy , if increased in size I will do a biopsy."
  3. distance 1.58: PI-RADS 4, PSA 6.7, PSAD 0.2, age 67, DRE Normal -> BIOPSY (borderline). He wrote: "Active surveillance, only one previous biopsy 2 yrs ago. Stable findings (stable PIRADS4, slightly increasing PSA) -> borderline indication for biopsy. As only one previ…"

PRECEDENT: DEFER (weighted vote 0.32 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · age = 64 · PI-RADS = 4
  noted      family history = not opened (0 of 91) · DRE = Normal · PSA = 19 ng/mL · prostate volume = 87.5 mL · PSA density = 0.217 · comorbidity = 3 on the problem list
  not used   csPCa probability
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 64 · PSA = 19 ng/mL · PI-RADS = 4
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 87.5 mL · PSA density = 0.217 · comorbidity = 3 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guidelines discuss using PI-RADS thresholds to guide biopsy decisions, noting that a PI-RADS score of $\\ge 3$ is used to trigger biopsy. The guideline also mentions that a PI-RADS threshold of $\\ge 4$ would have avoided 59% of all biopsy procedures while missing 28% of detected ISUP $\\ge 2$ cancers.

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, your bid of BIOPSY p(biopsy) = 0.56 is not settled by the guideline, as the guideline focuses on risk stratification via PI-RADS thresholds rather than a direct probability score. EXPERT-COHORT, your finding that the prior positive biopsy means the panel does not determine the decision is correct, but the guideline requires the documented grade of the prior biopsy to settle the decision. EXPERT-EXPERIENCE, your precedent suggests a DEFER decision, which aligns with the guideline's caution when the prior diagnosis is known, but the guideline needs the documented prior grade to be applied.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does
psa_trend - whether the PSA trend is significant: a rising PSA trend is a factor that must be considered in the context of the guideline's risk stratification
laboratory_results - whether the PSA density is below the threshold: a low PSA density is a factor in risk-adapted matrix tables
family-history anamnesis - whether the family history is present: the guideline suggests this is a factor in risk stratification

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case hinges on establishing the documented grade of the prior biopsy, as the guideline requires this information to settle the decision.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Does the lesion size or extraprostatic extension differ from an earlier study?
  psa_trend (get_psa_trend) -> Is the PSA trend significant?
  previous_notes (get_previous_notes) -> What is the grade (Gleason or ISUP) of the prior biopsy?

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the grade (Gleason or ISUP) of the prior biopsy?
  Q2. Is the PSA trend significant?
  Q3. Is the lesion in the radiology report compared against an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Prostate Multiparametric MRI | Facility: OLVG, Amsterdam | Date: 02 Feb 2025
Does the lesion size or extraprostatic extension differ from an earlier study? The report notes a discrete lesion spanning roughly 12 mm at its widest point, but does not explicitly state if this differs from an earlier study.
psa_trend
Is the PSA trend significant? The PSA trend shows a rise from 7.6 ng/mL (Oct 2022) to 7.3 ng/mL (Dec 2023), and then to 19.0 ng/mL (Feb 2025). The most recent change is from 7.3 to 19.0 ng/mL.
previous_notes
What is the grade (Gleason or ISUP) of the prior biopsy? The notes state: "Review of earlier biopsy material confirmed ISUP group 2 malignancy."

WHAT I DID NOT OPEN
family-history anamnesis, because the guideline focus was on the documented prior biopsy grade, which was found in the previous notes.

WHAT THIS SUPPORTS
FOR sampling this patient now
The previous notes state the prior biopsy confirmed ISUP group 2 malignancy, which is a factor in risk stratification.
The PSA trend shows a significant rise to 19.0 ng/mL, which is a factor to consider in the context of risk stratification.
AGAINST sampling this patient now
The previous notes document a prior biopsy result, which suggests the decision should be based on that documented grade rather than immediate re-biopsy.

WHERE THIS LEANS
LEAN: defer

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (clear). Last value 19.00 ng/mL over 3 points spanning 28 months; velocity +4.89 ng/mL per year; doubling time about 21 months.
PROJECTION at 6 months: 66.5 ng/mL, conformal 95% band 19.1-231.7.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  important  PSA = 19 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: clear — the conformal band clears the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.64
  uncertainty  +/- 0.08 epistemic (95% band 0.47-0.80), of which 0.01 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 56% of the time over the 25 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 19 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 87.5 mL (4% of my signal; from log_vol, vol) · PSA density = 0.217 (0% of my signal; from psad_calc) · comorbidity = 3 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 56% of the time over the 25 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.56  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.64  ('supports' tier, fusion_nolab; weight 3.0)
  EXPERT-EXPERIENCE  DEFER, p(biopsy)=0.32  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: weighted vote of the trained experts, p = 0.62 — carried by weighted panel.
PANEL ANSWER: BIOPSY. EXPERT-FUSION carried the most weight ('supports' tier, fusion_nolab). In this bucket no rule applied and the documents did not record the prior grade, so the trained experts decide.
Dissenting on the board: EXPERT-EXPERIENCE. Their bids are recorded above; they did not carry because a higher rung of the protocol applied.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          64                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          19 ng/mL                     E1:not E3:not cohort:not library:not E2:IMP          -> important
  vol          87.5 mL                      E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.217                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.79                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  3 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) directly address all three moderator questions.

ALIGNMENT WITH THE PANEL
The PANEL-PROTOCOL concludes BIOPSY based on a weighted vote (p=0.62), noting that the decision is based on the trained experts because the documented prior grade was not recorded in the opened documents. The retrieved information confirms the PSA trend is significant (rise to 19.0 ng/mL) and the prior biopsy was ISUP group 2 malignancy.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the grade (Gleason or ISUP) of the prior biopsy? Answered by previous_notes: ISUP group 2 malignancy.
Q2. Is the PSA trend significant? Answered by psa_trend: Yes, a rise from 7.3 to 19.0 ng/mL is significant.
Q3. Is the lesion in the radiology report compared against an earlier study? Answered by radiology_report: The report does not explicitly state if the lesion differs from an earlier study.

WHAT CARRIES WEIGHT, AND WHY
psa: important: 19 ng/mL, because the trajectory shows a significant rise to 19.0 ng/mL, which is a factor to consider in risk stratification. I would move this to decisive because the rise is clear.
prior biopsy: decisive: Positive, because the previous notes document a prior biopsy result of ISUP group 2 malignancy, which is a factor in risk stratification. I agree with the PANEL-PROTOCOL's reliance on this finding.
comorbidity: important: 3 on the problem list, as this was weighted by Expert-STRUCTURED, indicating its relevance in the overall decision process.

MY SUGGESTION TO THE CHAIR
The panel's decision to BIOPSY is supported by the retrieved evidence, particularly the documented ISUP group 2 malignancy and the significant PSA trend. The uncertainty regarding the comparison in the radiology report is noted, but the established prior diagnosis and rising PSA push the decision toward biopsy.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

64y/o, PSA 19.0, PI-RADS 4, prior positive biopsy with unrecorded grade. High PSA and unrecorded prior grade mandate sampling to determine management. The lack of prior grade is the deciding factor for proceeding with biopsy.

What carried weight: bx=important, age=important, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
